Fresenius Medical Care - 股票

Fresenius Medical Care 股本 2024

Fresenius Medical Care 股本

13.62 亿 EUR

股票代码

FME.DE

ISIN

DE0005785802

WKN

578580

在2024年,Fresenius Medical Care的股本为13.62 亿 EUR,比上一年的13.99 亿 EUR资本增长了-2.64%

Fresenius Medical Care Aktienanalyse

Fresenius Medical Care在做什么?

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius Medical Care 按部门划分的营业额

在Fresenius Medical Care股票(DE0005785802,578580,FME.DE)的财务报告中,将其营收分为4个细分市场: 1. North America, 2. EMEA, 3. Asia-Pacific, 4. Latin America. Fresenius Medical Care 股票(WKN: 578580,ISIN: DE0005785802,Ticker-Symbol: FME.DE)是对于有意投资于Health Care行业的投资者来说的一个领先投资选择。

  • 70 % North America

  • 15 % EMEA

  • 11 % Asia-Pacific

  • 4 % Latin America

股本的详细信息

Fresenius Medical Care的股本分析

Fresenius Medical Care的股本代表了公司的所有者权益,是总资产与总负债之间的差额。它反映了在所有债务都得到偿还之后,股东对公司资产的剩余权益。理解Fresenius Medical Care的股本对评估其财务健康,稳定性以及对股东的价值至关重要。

年对年比较

评估Fresenius Medical Care连续几年的股本,可以提供有关公司的增长,盈利能力以及资本结构的观点。股本的增长表明净资产和财务健康的改善,而股本的减少可能表明债务的增加或运营上的挑战。

对投资的影响

Fresenius Medical Care的股本对投资人来说是一个关键的元素,它影响了公司的杠杆,风险档案以及股本回报率(ROE)。较高的股本水平通常预示着较低的风险和增加的财务稳定性,使得公司可能成为有吸引力的投资机会。

解读股本波动

Fresenius Medical Care的股本波动可能源于各种因素,包括净利润的变动,分红,以及发行或回购股票。投资人分析这些变化,以评估公司的财务表现,运营效率和战略财务管理。

关于Fresenius Medical Care股票的常见问题

Fresenius Medical Care今年的股本是多少?

Fresenius Medical Care今年的股本为13.62 亿 EUR。

Fresenius Medical Care的股本与去年相比高了多少?

Fresenius Medical Care的股本与去年相比,-2.64下降了。

Fresenius Medical Care的投资者高额的股本会产生什么影响?

对于Fresenius Medical Care的投资者来说,高额的股本是有利的,因为它是公司财务稳定性的指标,展示了公司应对风险和挑战的能力。

Fresenius Medical Care的投资者低资本充足率会有什么影响?

对于Fresenius Medical Care的投资者来说,较低的自有资本可能构成风险,因为这会使公司处于较弱的财务地位,并可能影响其应对风险和挑战的能力。

Fresenius Medical Care的股本增加对公司有什么影响?

增加Fresenius Medical Care的股本可以强化公司的财务状况,提高其未来投资的能力。

Fresenius Medical Care的股本减少会如何影响公司?

Fresenius Medical Care的股本减少可能会影响公司的财务状况,并导致对债务资金的依赖度增加。

什么因素会影响Fresenius Medical Care的股本?

一些可能影响Fresenius Medical Care股本的因素包括利润,股息支付,增资和收购。

为什么Fresenius Medical Care的股本对投资者如此重要?

Fresenius Medical Care的股本对投资者非常重要,因为它是公司财务实力的指标,也可能是该公司有能力履行其财务义务的迹象。

Fresenius Medical Care可以采取哪些战略措施来改变自己的股本?

为了改变自身的股本,Fresenius Medical Care可以采取包括提高利润,实施增资,减少开支和收购企业等多种措施。对公司来说,彻底检查其财务状况以确定最佳的策略性措施来改变其股本的情况非常重要。

Fresenius Medical Care支付多少股息?

在过去的12个月中,Fresenius Medical Care支付了1.12 EUR 的股息。这相当于大约3.14 %的股息收益率。在未来的12个月内,Fresenius Medical Care预计将支付1.14 EUR的股息。

Fresenius Medical Care的股息收益率有多高?

Fresenius Medical Care当前的股息收益率为3.14 %。

Fresenius Medical Care什么时候支付股息?

Fresenius Medical Care按季度支付股息。这些股息将在, , , 月份分发。

Fresenius Medical Care的股息有多安全?

Fresenius Medical Care 在过去33年里每年都支付了股息。

Fresenius Medical Care的股息有多高?

预计未来12个月的股息将达到1.14 EUR。这相当于3.2 %的股息收益率。

Fresenius Medical Care位于哪个行业?

Fresenius Medical Care 被分配到“健康”板块。

Wann musste ich die Aktien von Fresenius Medical Care kaufen, um die vorherige Dividende zu erhalten?

要获得Fresenius Medical Care在支付的1.19 EUR的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Fresenius Medical Care最后一次支付股息是什么时候?

上一次股息发放日期为。

Fresenius Medical Care在2023年的股息是多少?

在2023年,Fresenius Medical Care 分配了1.35 EUR作为股息。

Fresenius Medical Care 的股息是以哪种货币支付的?

Fresenius Medical Care的股息将以EUR的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Fresenius Medical Care 股票在以下供应商处可进行定投计划:Trade Republic, ING, Scalable Capital 与 Consorsbank

Andere Kennzahlen von Fresenius Medical Care

我们对Fresenius Medical Care 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Fresenius Medical Care 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: